MoonLake Immunotherapeutics share price logo

MoonLake Immunotherapeutics

NASDAQ: MLTX

Small Cap

$12.04

-0.08

(-0.66%)

as on

MoonLake Immunotherapeutics Stock Performance

as on September 26, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $11.80
    $12.20
    downward going graph

    1.99%

    Downside

    1.33%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $5.95
    $62.75
    downward going graph

    50.58%

    Downside

    421.18%

    Upside

    downward going graph

MoonLake Immunotherapeutics share price movements today

Previous Close
$12.12
Open
$12.15
Volume
1.8M
Market Cap
$1.0B
Day's Low - High
$11.80 - $12.20
52 Week Low - High
$5.95 - $62.75

MoonLake Immunotherapeutics Historical Returns

1 Month Return
-22.92 %
3 Month Return
-39.5 %
1 Year Return
-80.58 %
3 Year Return
-78.31 %
5 Year Return
0 %

MoonLake Immunotherapeutics Stock Fundamentals & Key Indicators

Check MoonLake Immunotherapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.0B

EPS (TTM)

-3.85

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.15

Industry PE ratio

-8.07

PEG Ratio

0.1000044669192959

EBITDA

-250.8M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-82.68%

MoonLake Immunotherapeutics Stock Valuation

Track how MoonLake Immunotherapeutics P/E has moved over time to understand its valuation trends.

MoonLake Immunotherapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-82.39x)

December 31, 2023

Industry (-8.07x)

December 31, 2025

Today (-3.73x)

December 31, 2025

Highest (-3.73x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -3.73x

MoonLake Immunotherapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of MoonLake Immunotherapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
MoonLake Immunotherapeutics image
MoonLake Immunotherapeutics
StrongBuy$1.0BNA-3.150.00%0.00%
Moderna image
Moderna
Neutral$77.8B-53.76%-24.41-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$132.4B186.58%30.1686.04%0.00%
Regeneron image
Regeneron
Buy$82.8B23.34%19.0184.86%0.46%

Stock Returns calculator for MoonLake Immunotherapeutics Stock including INR - Dollar returns

The MoonLake Immunotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

MoonLake Immunotherapeutics investment value today

Current value as on today

₹20,987

Returns

-₹79,013

(-79.01%)

Returns from MoonLake Immunotherapeutics Stock

-₹80,578 (-80.58%)

Dollar Impact

₹1,564 (+1.56%)

Analyst Recommendation on MoonLake Immunotherapeutics Stock

Based on 6 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 6 analysts, 83.33333333333334% of analysts recommend a 'BUY' rating for MoonLake Immunotherapeutics. Average target price of $28.54

MoonLake Immunotherapeutics Share Price Target

Get share price movements and forecasts by analysts on MoonLake Immunotherapeutics.

What analysts predicted

57.81%UPSIDE

Target Price

$28.54

Current Price

$12.04

Analyzed by

6 Analysts

High

$50

Target

$28.54

Low

$17

MoonLake Immunotherapeutics target price $28.54, a slight upside of 57.81% compared to current price of $12.04. According to 6 analysts rating.

Indian Investors' Interest in MoonLake Immunotherapeutics Stock

Search interest for MoonLake Immunotherapeutics Stock has increased by 18% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:18% versus previous 30 day period

MoonLake Immunotherapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
0
-
-
0
-
0
0
-
Operating Income
-19
-30
-43
-49
-47
-60
-71
-65
-70
-61
EBITDA
-13
-24
-35
-45
-40
-53
-66
-60
-65
-58
Interest Expense
-
-
-
-
0
2
3
1
2
2
Depreciation
0
0
0
1
0
0
0
0
0
0
Income Before Tax
-13
-24
-36
-46
-40
-55
-70
-62
-69
-61
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-13
-24
-35
-45
-39
-55
-69
-62
-69
-61
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

MoonLake Immunotherapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
-
0
-
-
-
-2
Operating Income
0
-53
-65
-54
-143
-244
EBITDA
0
-53
-64
-43
-119
-219
Interest Expense
-
-
-
-
-
7
Depreciation
-
0
0
0
1
2
Income Before Tax
0
-53
-64
-43
-120
-229
Income Tax Expense
-
0
0
0
0
0
Net Income
0
-53
-49
-36
-118
-227
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

MoonLake Immunotherapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-13
-24
-36
-46
-40
-56
-70
-63
-69
-61
Operating Cash Flow
-14
-27
-25
-48
-38
-54
-44
-58
-66
-55
Investing Cash Flow
-28
-87
58
-147
56
88
88
-29
0
0
Financing Cash Flow
50
-
0
0
73
-
0
72
30
234
Change in Cash
7
-115
32
-195
91
35
44
-16
-36
179

MoonLake Immunotherapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-53
-64
-44
-121
-229
Operating Cash Flow
0
-35
-55
-42
-116
-196
Investing Cash Flow
-115
0
-32
-25
-205
202
Financing Cash Flow
116
43
119
479
51
145
Change in Cash
1
6
31
411
-270
154

Mutual Funds that own MoonLake Immunotherapeutics Stock

Check out the Mutual Funds with significant holdings in MoonLake Immunotherapeutics.

Funds
Holdings
Shares Held
T. ROWE PRICE HEALTH SCIENCES FUND, INC.
1.042255%
887029
Delaware Group Equity Funds IV
0.187999%
160000
Fidelity Select Portfolios
0.16868%
143558
VANGUARD WORLD FUND
0.112475%
95724
Victory Portfolios III
0.078608%
66901
See all

Global Institutional Holdings in MoonLake Immunotherapeutics

Funds
Holdings
T. ROWE PRICE HEALTH SCIENCES FUND, INC.
1.04%
Xtrackers
0.47%
T. Rowe Price
0.32%
iShares
0.19%
Delaware Group Equity Funds IV
0.19%
See all

MoonLake Immunotherapeutics News & Key Events

    Insights on MoonLake Immunotherapeutics

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Moderna, Inc. Common Stock has given 712.1% return, outperforming this stock by 792.7%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Moderna, Inc. Common Stock has given 100.0% return, outperforming this stock by 178.3%

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 1 month, MLTX stock has moved down by -22.5%

    About MoonLake Immunotherapeutics

    MoonLake Immunotherapeutics operates as a clinical-stage biopharmaceutical company, concentrating its efforts on discovering and developing novel therapies. The company's primary focus is the advancement of Sonelokimab, an innovative, investigational Nanobody-based treatment engineered to target inflammatory conditions. Currently, Sonelokimab is undergoing mid-stage (Phase II) clinical trials for a range of inflammatory diseases, including hidradenitis suppurativa, psoriatic arthritis, and both ankylosing spondylitis and radiographic axial spondyloarthritis. Established in 2021, MoonLake Immunotherapeutics is based in Zug, Switzerland.
    OrganisationMoonLake Immunotherapeutics
    HeadquartersDorfstrasse 29, Zug, ZG, 6300, CH
    IndustryBiotechnology
    CEOJorge Santos da Silva
    E-voting on sharesClick here to vote

    Key Management of MoonLake Immunotherapeutics

    Name

    Title

    Luciana Marques

    Associate Vice-President of HR, People and Culture

    Dr. Kristian Reich M.D., Ph.D.

    Co-Founder & Chief Scientific Officer

    Ms. Carla Bretes

    Director of Investor Relations & External Communications

    Tino Anthamatten

    Vice President of Marketing, Market Access & Pricing

    Mr. Nicolas Mosimann Ph.D.

    General Counsel

    Joana Cortez

    Associate Vice-President of Legal & Compliance

    Ms. Nuala Brennan

    Chief Clinical Development Officer

    Dr. Jorge Santos da Silva Ph.D.

    Co-Founder, Interim Chair of the Board & CEO

    Mr. Matthias Bodenstedt

    Chief Financial Officer

    Mr. Oliver Daltrop Ph.D.

    Chief Technical Officer

    FAQs

    What is MoonLake Immunotherapeutics share price today?

    MoonLake Immunotherapeutics share price today is $12.04 as on at the close of the market. MoonLake Immunotherapeutics share today touched a day high of $12.20 and a low of $11.80.

    What is the 52 week high and 52 week low for MoonLake Immunotherapeutics share?

    MoonLake Immunotherapeutics share touched a 52 week high of $62.75 on and a 52 week low of $5.95 on . MoonLake Immunotherapeutics stock price today i.e. is closed at $12.04,which is 80.81% down from its 52 week high and 102.35% up from its 52 week low.

    What is MoonLake Immunotherapeutics's market capitalisation today?

    MoonLake Immunotherapeutics market capitalisation is $0.00T as on .

    How to invest in MoonLake Immunotherapeutics Stock (MLTX) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for MoonLake Immunotherapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in MoonLake Immunotherapeutics Shares that will get you 0.1246 shares as per MoonLake Immunotherapeutics share price of $12.04 per share as on September 26, 2026 at 8:46 am IST.

    What is the minimum amount required to buy MoonLake Immunotherapeutics Stock (MLTX) from India?

    Indian investors can start investing in MoonLake Immunotherapeutics (MLTX) shares with as little as ₹95.819999694824 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹958.20 in MoonLake Immunotherapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on MoonLake Immunotherapeutics share’s latest price of $12.04 as on September 26, 2026 at 8:46 am IST, you will get 0.8306 shares of MoonLake Immunotherapeutics. Learn more about fractional shares .